The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST

Nanotoxicology

Volumn 9, Issue S1, 2015, Pages 66-78

  Correia Carreira, Sara ^a   Walker, Laura ^a   Paul, Kai ^b   Saunders, Margaret ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

^c ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

Barrier transport; Kinetics; Nanotoxicity; Risk assessment

Indexed keywords

INTERLEUKIN 6; SILICA NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; MAGNETITE NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE;

APPARENT PERMEABILITY; ARTICLE; BLOOD PLACENTA BARRIER; CELL VIABILITY; CHORIOCARCINOMA CELL LINE; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; NANOTOXICOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE PROPERTY; TIGHT JUNCTION; ZETA POTENTIAL; BIOLOGICAL MODEL; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; PLACENTA; PREGNANCY; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL LINE; FEMALE; HUMANS; MAGNETITE NANOPARTICLES; MODELS, BIOLOGICAL; NANOPARTICLES; PLACENTA; PREGNANCY; SILICON DIOXIDE; TISSUE DISTRIBUTION;

EID: 84930007066     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.833317     Document Type: Article

References (73)

1. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. 2008. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5(4):505-515.
2. Andreas K, Georgieva R, Ladwig M, Mueller S, Notter M, Sittinger M, et al. 2012. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials 33(18):4515-4525.
3. Brunner TJ, Wick P, Manser P, Spohn P, Robert N, Limbach LK, et al. 2006. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40(14):4374-4381.
4. Buerki-Thurnherr T, von Mandach U, Wick P. 2012. Knocking at the door of the unborn child: engineered nanoparticles at the human placental barrier. Swiss Med Weekly 142:w13559.
5. Cartwright L, Poulsen MS, Nielsen HM, Pojana G, Knudsen LE, Saunders M, et al. 2012. In vitro placental model optimization for nanoparticle transport studies. Int J Nanomedicine 7:497-510.
6. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes VF. 2011. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. Small 7(24):3479-3486.
7. Chithrani BD, Chan WC. 2007. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7(6):1542-1550.
8. Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662-668.
9. Choi J, Burns AA, Williams RM, Zhou Z, Flesken-Nikitin A, Zipfel WR, et al. 2007. Core-shell silica nanoparticles as fluorescent labels for nanomedicine. J Biomed Opt 12(6):064007-064011.
10. Choi KY, Liu G, Lee S, Chen X. 2012. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 4(2):330-342.
11. Chu M, Wu Q, Yang H, Yuan R, Hou S, Yang Y, et al. 2010. Transfer of quantum dots from pregnant mice to pups across the placental barrier. Small 6(5):670-678.
12. Corot C, Petry KG, Trivedi R, Saleh A, Jonkmanns C, Le Bas J-F, et al. 2004. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 39(10):619-625.
13. Costa CS, Ronconi JVV, Daufenbach JF, Gonçalves CL, Rezin GT, Streck EL, et al. 2010. In vitro effects of silver nanoparticles on the mitochondrial respiratory chain. Mol Cell Biochem 342(1-2):51-56.
14. Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden PE, Bartonova A, et al. 2009. Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (London, England) 4(6):605.
15. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM. 2011. Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol 45(1):283-287.
16. Ema M, Kobayashi N, Naya M, Hanai S, Nakanishi J. 2010. Reproductive and developmental toxicity studies of manufactured nanomaterials. Reprod Toxicol 30(3):343-352.
17. Fadeel B, Garcia-Bennett AE. 2010. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 62(3):362-374.
18. Fazlollahi F, Angelow S, Yacobi NR, Marchelletta R, Yu AS, Hamm-Alvarez SF, et al. 2011. Polystyrene nanoparticle trafficking across MDCK-II. Nanomedicine 7(5):588-594.
19. Gambarota G, van Laarhoven HW, Philippens M, Peeters WJ, Rijken P, van der Kogel A, et al. 2010. Assessment of blood hemodynamics by USPIO-induced R 1 changes in MRI of murine colon carcinoma. Appl Magn Reson 38(3):349-360.
20. Gao J, Hugger ED, Beck-Westermeyer MS, Borchardt RT. 2000. Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayers. In: Enna SJ, Williams M, Ferkany JW, Kenakin T, Porsolt RE, Sullivan JP, editors. Current protocols in pharmacology. New York: John Wiley & Sons, Unit 7.2. pp 1-23.
21. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. 2004. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15(4):897-900.
22. Guadagnini R, Halamoda B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. 2015. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(S1):13-24.
23. Halamoda Kenzaoui B, Bernasconi CC, Hofmann H, Juillerat-Jeanneret L. 2012b. Evaluation of uptake and transport of ultrasmall super-paramagnetic iron oxide nanoparticles by human brain-derived endo-thelial cells. Nanomedicine 7(1):39-53.
24. Halamoda Kenzaoui B, Chapuis Bernasconi C, Guney-Ayra S, Juillerat-Jeanneret L. 2012c. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem J 441(3):813-821.
25. Halamoda Kenzaoui B, Vilà MR, Miquel JM, Cengelli F, Juillerat-Jeanneret L. 2012a. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int J Nanomedicine 7:1275-1286.
26. Harush-Frenkel O, Rozentur E, Benita S, Altschuler Y. 2008. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9(2):435-443.
27. Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, et al. 2011. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77(3):407-416.
28. Hsiao EY, Patterson PH. 2012. Placental regulation of maternal-fetal interactions and brain development. Dev Neurobiol 72(10):1317-1326.
29. Iversen NK, Frische S, Thomsen K, Laustsen C, Pedersen M, Hansen PB, et al. 2012. Superparamagnetic iron oxide polyacrylic acid coated g-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol Appl Pharmacol 266(2):276-288.
30. Jiang YJ, Lu B, Crumrine D, Elias PM, Feingold KR. 2010. IL-6 stimulates but is not essential for stratum corneum formation and permeability barrier development during gestation. Exp Dermatol 19(8):e31-e36.
31. Johnston H, Pojana G, Zuin S, Jacobsen NR, Møller P, Loft S, et al. 2013. Engineered nanomaterial risk. Lessons learnt from completed nano-toxicology studies: potential solutions to current and future challenges. Crit Rev Toxicol 43(1):1-20.
32. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40(4):328-346.
33. Jones HN, Ashworth CJ, Page KR, McArdle HJ. 2006. Cortisol stimulates system A amino acid transport and SNAT2 expression in a human placental cell line (BeWo). Am J Physiol Endocrinol Metab 291(3): E596-E603.
34. Kim J-S, Yoon T-J, Yu K-N, Noh MS, Woo M, Kim B-G, et al. 2006. Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J Vet Sci 7(4):321-326.
35. King BF. 1992. Comparative studies of structure and function in mammalian placentas with special reference to maternal-fetal transfer of iron. Am Zool 32:331-342.
36. Kumagai M, Sarma TK, Cabral H, Kaida S, Sekino M, Herlambang N, et al. 2010. Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. Macromol Rapid Commun 31(17): 1521-1528.
37. Lahtinen U, Honsho M, Parton RG, Simons K, Verkade P. 2003. Involvement of caveolin-2 in caveolar biogenesis in MDCK cells. FEBS Lett 538(1-3):85-88.
38. Leroueil PR, Berry SA, Duthie K, Han G, Rotello VM, McNerny DQ, et al. 2008. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett 8(2):420-424.
39. Leroueil PR, Hong S, Mecke A, Baker Jr JR, Orr BG, Banaszak Holl MM. 2007. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc Chem Res 40(5):335-342.
40. Liu F, Soares MJ, Audus KL. 1997. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol 273(5):C1596-C1604.
41. Mahmoudi M, Serpooshan V, Laurent S. 2011. Engineered nanoparticles for biomolecular imaging. Nanoscale 3(8):3007-3026.
42. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW. 2007. Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150(5):552-558.
43. Menjoge AR, Rinderknecht AL, Navath RS, Faridnia M, Kim CJ, Romero R, et al. 2011. Transfer of PAMAM dendrimers across human placenta: Prospects of its use as drug carrier during pregnancy. J Control Release 150(3):326-338.
44. MHRA. 2007. Device bulletin. Safety guidelines for Magnetic Resonance Imaging equipment in clinical use. Department of Health. http://www.mhra.gov.uk/home/groups/dts-iac/documents/publication/con2033065.pdf.Accessed on 27 March 2013.
45. Myllynen PK, Loughran MJ, Howard CV, Sormunen R, Walsh AA, Vähäkangas KH. 2008. Kinetics of gold nanoparticles in the human placenta. Reprod Toxicol 26(2):130-137.
46. Nam J, Won N, Bang J, Jin H, Park J, Jung S, et al. 2012. Surface engineering of inorganic nanoparticles for imaging and therapy. Adv Drug Deliv Rev 65(5):622-648.
47. Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, Prashant C, et al. 2010. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomedicine 5:983-989.
48. Nyström AM, Fadeel B. 2012. Safety assessment of nanomaterials: implications for nanomedicine. J Control Release 161(2):403-408.
49. Poulsen MS, Mose T, Maroun LL, Mathiesen L, Knudsen LE, Rytting E. 2015. Kinetics of silica nanoparticles in the human placenta. Nanotoxicology 9(S1):79-86.
50. Qiao R, Yang C, Gao M. 2009. Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications. J Mater Chem 19(35):6274-6293.
51. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. 1994. The role of cytokines in gestation. Crit Rev Immunol 14(3-4):239-292.
52. Rosen JE, Chan L, Shieh DB, Gu FX. 2012. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine 8(3):275-290.
53. Rümenapp C, Gleich B, Haase A. 2012. Magnetic nanoparticles in magnetic resonance imaging and diagnostics. Pharm Res 29:1165-1179.
54. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, et al. 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:10.
55. Saunders M. 2009. Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(6):671-684.
56. Sekhon BS, Kamboj SR. 2010. Inorganic nanomedicine-part 1. Nanomedicine 6(4):516-522.
57. Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, et al. 2008. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4(12):2108-2111.
58. Singh N, Jenkins GJ, Asadi R, Doak SH. 2010. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1:doi: 10.3402/nano.v3401i3400.5358.
59. Sumner SC, Fennell TR, Snyder RW, Taylor GF, Lewin AH. 2010. Distribution of carbon-14 labeled C60 ([14C]C60) in the pregnant and in the lactating dam and the effect of C60 exposure on the biochemical profile of urine. J Appl Toxicol 30(4):354-360.
60. Tang F, Li L, Chen D. 2012. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24(12):1504-1534.
61. Tang J, Xiong L, Wang S, Wang J, Liu L, Li J, et al. 2009. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9(8):4924.
62. Teodoro JS, Simões AM, Duarte FV, Rolo AP, Murdoch RC, Hussain SM, et al. 2011. Assessment of the toxicity of silver nanoparticles in vitro: a mitochondrial perspective. Toxicol In Vitro 25(3):664-670.
63. Unfried K, Albrecht C, Klotz L-O, Von Mikecz A, Grether-Beck S, Schins RP. 2007. Cellular responses to nanoparticles: Target structures and mechanisms. Nanotoxicology 1(1):52-71.
64. Wahajuddin SA. 2012. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 7: 3445-3471.
65. Wang S-H, Lee C-W, Chiou A, Wei P-K. 2010. Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J Nanobiotechnology 8(1):33.
66. Wick P, Malek A, Manser P, Meili D, Maeder-Althaus X, Diener L, et al. 2010. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect 118(3):432.
67. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, et al. 2011. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 6(5):321-328.
68. Yang F, Jin C, Subedi S, Lee CL, Wang Q, Jiang Y, et al. 2012. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment. Cancer Treat Rev 38(6):566-579.
69. Yigit MV, Moore A, Medarova Z. 2012. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res 29:1180-1188.
70. Zhang L, He R, Gu H-C. 2006. Oleic acid coating on the monodisperse magnetite nanoparticles. Appl Surface Sci 253(5):2611-2617.
71. Zhao W, Wang L, Tan W. 2007. Fluorescent nanoparticle for bacteria and DNA detection. Bio-Applications of Nanoparticles: Springer. Adv Exp Med Biol 620:129-135.
72. Zhong W. 2009. Nanomaterials in fluorescence-based biosensing. Anal Bioanal Chem 394(1):47-59.
73. Zou P, Yu Y, Wang YA, Zhong Y, Welton A, Galbán C, et al. 2010. Superparamagnetic iron oxide ''nanotheranostics'' for targeted cancer cell imaging and pH-dependent intracellular drug release. Mol Pharm 7(6):1974.